Abzena Share News (ABZA)

Abzena Shares Suspended As Acquisition Becomes Effective (ALLISS)

LONDON (Alliance News) - Abzena PLC shares were suspended from trading on AIM on Thursday as the company's acquisition by Astro BidCo Ltd became effective.The biopharmaceutical firm its

Abzena Acquisition By Astro Bidco Gains Shareholder Approval

LONDON (Alliance News) - Biopharmaceutical technology firm Abzena PLC said on Tuesday that at a court meeting and general meeting held earlier, its acquisition by Astro Bidco Ltd was approved by a

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 11 SeptemberAshtead GroupBilbyCohortMulberry 12 Direct Oil & UK 13 14 UK

WINNERS & LOSERS SUMMARY: Acquisition Puts On The Beach On Buying Wave

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - down 2.6%, Legal & down down 0.7%,

Abzena agrees to be taken over by US private equity firm WCAS

(Sharecast News) - Abzena has agreed to be taken over by US private equity firm WCAS in a £34.4m deal.

Abzena To Go Private As It Agrees GBP34 Million Takeover By Astro

LONDON (Alliance News) - Shares in biopharmaceutical technology firm Abzena PLC rocketed Thursday after agreed to a takeover valuing the firm at around GBP34.4 million.Astro Bidco Ltd, a up

Shares In Abzena Fall As It Seeks To Monetise Royalty-Bearing Products

LONDON (Alliance News) - Abzena PLC on Thursday said it has entered into a non-binding heads of terms agreement with an unconnected third party as it requires additional funding to support its in

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2.6%. The jet engine maker said it will cut

WINNERS & LOSERS SUMMARY: Shares Of Upbeat Synthomer Hit Record High

Abzena signs licensing agreement for 'ThioBridge' technology

(ShareCast News) - Life sciences group Abzena announced on Friday that it has signed a licensing agreement with an unnamed San Diego-based biopharmaceutical company for its site-specific 'ThioBridge' antibody drug conjugate linker technology. The AIM-traded company said 'ThioBridge' links antibodies

Abzena Shares Jump On ThioBridge Licensing Agreement In US

Abzena inks licence agreement with Trieza Therapeutics

(ShareCast News) - Life-sciences group Abzena has inked a licence agreement with start-up biotechnology company Trieza Therapeutics. US-based Trieza specialises in the discovery and development of immunomodulatory oncolytic viruses. Abzena has granted Trieza an exclusive licence to an undisclosed a

Abzena shares plunge as Gilead drops simtuzumab

(ShareCast News) - Life sciences group Abzena noted on Wednesday that during Gilead Sciences' announcement of third quarter earnings on 1 November, it stated that no further development of simtuzumab will be pursued. The AIM-traded firm also noted that GS-5745 will not be progressed further by Gilea

Abzena notes progress with Composite Human Antibody tech

(ShareCast News) - Life sciences group Abzena noted on Friday that Gilead Sciences has announced top line Phase II clinical study results of its product, GS-4997 (selonsertib) in combination with the investigational monoclonal antibody, simtuzumab (SIM) or SIM alone, in patients with non-alcoholic s

UK Shareholder Meetings Calendar - Next 7 Days